Vancomycin-Loaded Collagen/Hydroxyapatite Layers Electrospun on 3D Printed Titanium Implants Prevent Bone Destruction Associated with <i>S. epidermidis</i> Infection and Enhance Osseointegration

• Main Authors: Tomáš Suchý, Lucie Vištejnová, Monika Šupová, Pavel Klein, Martin Bartoš, Yaroslav Kolinko, Tereza Blassová, Zbyněk Tonar, Marek Pokorný, Zbyněk Sucharda, Margit Žaloudková, František Denk, Rastislav Ballay, Štefan Juhás, Jana Juhásová, Eva Klapková, Lukáš Horný, Radek Sedláček, Tomáš Grus, Zdeněk Čejka, Kateřina Chudějová, Jaroslav Hrabák
• Format: Article
• Language: English
• Published: MDPI AG 2021-05-01
• Series: Biomedicines
• Subjects: orthopedic implant; collagen; hydroxyapatite; vancomycin; implant-related bone infection; <i>Staphylococcus epidermidis</i>
• Online Access: https://www.mdpi.com/2227-9059/9/5/531

The aim of the study was to develop an orthopedic implant coating in the form of vancomycin-loaded collagen/hydroxyapatite layers (COLHA+V) that combine the ability to prevent bone infection with the ability to promote enhanced osseointegration. The ability to prevent bone infection was investigated employing a rat model that simulated the clinically relevant implant-related introduction of bacterial contamination to the bone during a surgical procedure using a clinical isolate of <i>Staphylococcus epidermidis</i>. The ability to enhance osseointegration was investigated employing a model of a minipig with terminated growth. Six weeks following implantation, the infected rat femurs treated with the implants without vancomycin (COLHA+<i>S. epidermidis</i>) exhibited the obvious destruction of cortical bone as evinced via a cortical bone porosity of up to 20% greater than that of the infected rat femurs treated with the implants containing vancomycin (COLHA+V+<i>S. epidermidis</i>) (3%) and the non-infected rat femurs (COLHA+V) (2%). The alteration of the bone structure of the infected COLHA+<i>S. epidermidis</i> group was further demonstrated by a 3% decrease in the average Ca/P molar ratio of the bone mineral. Finally, the determination of the concentration of vancomycin released into the blood stream indicated a negligible systemic load. Six months following implantation in the pigs, the quantified ratio of new bone indicated an improvement in osseointegration, with a two-fold bone ingrowth on the COLHA (47%) and COLHA+V (52%) compared to the control implants without a COLHA layer (27%). Therefore, it can be concluded that COLHA+V layers are able to significantly prevent the destruction of bone structure related to bacterial infection with a minimal systemic load and, simultaneously, enhance the rate of osseointegration.